Corynebacterium coyleae is a bacterial species commonly found as part of the normal microbial flora inhabiting various human body sites, including the skin, urethra, mucous membranes, and genital tract. However, under certain circumstances, particularly in individuals with underlying medical conditions or compromised immune systems, C. coyleae can become pathogenic and lead to infections.
When considering the epidemiological and numerical data related to C. coyleae infections, it’s crucial to note that such cases are relatively rare. Research conducted in Poland over 22 months found that C. coyleae accounted for only 0.32% of cultured urine samples, indicating its infrequent occurrence as a urinary tract pathogen.
Additionally, C. coyleae is not commonly isolated from other clinical samples such as blood cultures, pleural fluid, or soft tissue, although it has been implicated in pancreatic abscesses.Since its initial description in 1997, there have been only a few reported cases of C. coyleae infections in the medical literature. These cases have been associated with various clinical presentations, including fever of unknown origin, sepsis, and post-surgical complications.
Some instances have also been linked to specific conditions such as HIV infection, neonatal bacteremia, burn injuries, and ulcers. Although there have been no reported outbreaks of C. coyleae infection, it’s worth noting that two patients from the same hospital were found to have identical strains of the bacterium isolated from their blood cultures, raising the possibility of nosocomial transmission.
Finally, concerning the clinical outcomes and antibiotic resistance patterns associated with C. coyleae infections, a study reported a mortality rate of 16.7% among patients with C. coyleae bacteremia. Regarding antibiotic susceptibility, C. coyleae exhibited high resistance rates to ciprofloxacin and erythromycin but remained susceptible to vancomycin and linezolid, highlighting the importance of appropriate antibiotic selection in managing infections caused by this bacterium.
Classification and Structure:
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Mycobacteriales
Family: Corynebacteriaceae
Genus:Corynebacterium
Species:Corynebacterium coyleae
Corynebacterium coyleae are slender, straight, or slightly curved rods, typically exhibiting clubbing at one or both sides due to the presence of metachromatic granules, which store phosphate reserves.
Their dimensions typically range from 2 to 6 μm in length & 0.5 μm in diameter. These bacteria are catalase-positive, capable of breaking down hydrogen peroxide into water and oxygen.
Unlike some bacteria, they do not form spores—resistant structures for survival in harsh conditions. Furthermore, Corynebacterium coyleae lack flagella, whip-like appendages used by certain bacteria for movement.
Corynebacterium coyleae shares certain antigens, such as cell wall lipoteichoic acid (LTA) and the iron-regulated surface determinant (ISD) system, with the pathogenic bacterium Corynebacterium diphtheriae, known for causing diphtheria—a potentially fatal respiratory infection. These shared antigens contribute to C. coyleae‘s ability to adhere to host tissues, invade them, and evade host immune responses, shedding light on its pathogenic mechanisms.
Moreover, C. coyleae possesses genes like biofilm-associated protein (bap), promoting biofilm formation, and corynomycolic acid synthase (mas), responsible for synthesizing corynomycolic acids—a component of the bacterial cell envelope that confers resistance to antibiotics and host defenses.
These genetic attributes enhance C. coyleae‘s virulence and resistance capabilities.Numerous strains of C. coyleae, including CCUG 38194, DSM 44184, ATCC 700219, JCM 10381, and CCM 4669, have been documented in scientific literature, underlining this bacterium’s diversity and clinical significance.
Corynebacterium coyleae possesses several distinctive traits contributing to its pathogenic potential and clinical impact. One of its notable abilities is its ability to breach and adhere to human epithelial cells, particularly in the urinary tract. This capability is facilitated by the expression of fimbriae, hair-like appendages crucial in mediating bacterial attachment to host cells. This adherence and invasion can lead to urinary tract infections, causing discomfort and clinical symptoms in affected individuals.
In addition to urinary tract infections, C. coyleae has been associated with the development of necrotizing fasciitis, an exceptionally severe and potentially life-threatening infection characterized by the rapid destruction of soft tissues. This condition can escalate swiftly and necessitates immediate medical intervention to prevent its potentially fatal consequences. Furthermore, C. coyleae infections, particularly in the pancreas, may mimic malignant tumors, necessitating surgical drainage for resolution.
Another notable aspect of C. coyleae‘s pathogenicity is its capacity to form biofilms. Biofilms grow as complex communities of bacterial colonies encased in a protective matrix, which can enhance their persistence and resistance to antibiotics. This protective mechanism can make C. coyleae infections challenging to treat, as they may become more resistant to antimicrobial therapies.
Additionally, C. coyleae may exhibit intrinsic or acquired resistance to various antibiotics, including erythromycin and clindamycin, further complicating treatment strategies. In some cases, C. coyleae‘s ability to evade the effects of antibiotics can lead to persistent or recurrent infections in affected patients,
The human host defense against Corynebacterium coyleae, a prominent member of the skin microbiota, involves a fascinating interplay with the immune system, particularly the activation of γδ T cells and the modulation of immune responses:
Corynebacterium coyleae can induce a significant increase in both the number and activation of a specific subset of γδ T cells within the skin. This activation is characterized by the production of interleukin-17A (IL-17A), a crucial cytokine in immune responses.
Notably, this effect is enduring and occurs independently of other microbial influences, underscoring the unique relationship between C. coyleae and these γδ T cells. The involvement of interleukin-23 (IL-23) in mediating this response further highlights the complexity of the host’s immune defense mechanisms against C. coyleae.
While Corynebacterium coyleae displays the capacity to activate γδ T cells and induce IL-17A production, it’s important to note that the influence of different Corynebacterium species on host immunity may vary.
This species-specific impact adds complexity to the intricate interactions between the host’s immune system and distinct members of the skin microbiota.The immunomodulatory properties of certain Corynebacterium species, exemplified by Corynebacterium parvum, have been explored in experimental vaccine trials.
These studies have demonstrated that specific Corynebacterium species can enhance immune responses, including CD4+ and CD8+ T cell responses, interferon-gamma (IFN-γ) production, and T cell proliferation. The potential adjuvant effects of these bacteria can significantly bolster the host’s immune defenses, as evidenced by prolonged IFN-γ production and T cell proliferation following vaccination.
Corynebacterium coyleae is associated with various clinical manifestations, primarily affecting different body systems. In urinary tract infections (UTIs), C. coyleae commonly afflicts women and men to a lesser extent. UTI symptoms encompass frequent urination, dysuria, a sense of urgency, hematuria (blood in the urine), and lower abdominal discomfort.
Moreover, C. coyleae can advance into the bloodstream, precipitating bacteremia—a grave condition that can potentially lead to sepsis and shock. Manifestations of bacteremia involve fever, chills, hypotension (low blood pressure), tachycardia (rapid heartbeat), and signs of organ dysfunction.
This pathogen is not confined to the urinary tract; it can invade the skin and soft tissues, culminating in inflammation, pain, swelling, erythema (redness), and pus formation. These soft tissue infections can extend into subcutaneous layers, muscles, fascia, or bone.
Additionally, C. coyleae can infect the pancreas, precipitating the formation of abscesses inside the organ. Symptoms indicative of a pancreatic abscess include abdominal pain, nausea, vomiting, unintended weight loss, and fever.
Diagnosing Corynebacterium coyleae infections involves several laboratory techniques and tests to identify and differentiate this bacterium from other species accurately. These diagnostic methods are essential for effective clinical management:
Culture: One of the primary diagnostic methods for C. coyleae is culturing clinical specimens, including blood, urine, pleural fluid, soft tissue, and pancreatic abscess samples. These specimens are typically cultured on specialized media such as chocolate agar & blood agar under aerobic conditions at 35°C for 24 to 48 hours. C. coyleae colonies typically appear small, smooth, and convex and range in color from white to gray. They are nonhemolytic and may exhibit a distinctive brown halo on Tinsdale agar due to hydrogen sulfide production.
Gram Stain: Gram staining is a valuable initial step in identifying C. coyleae. Under the microscope, C. coyleae cells appear Gram-positive and are typically present as thin, straight, or slightly curved rods. They may exhibit clubbing at the ends due to the presence of metachromatic granules, and their arrangement can be irregular, including palisades, V-shapes, or Chinese letter formations.
Biochemical Reactions:C. coyleae can be differentiated from other corynebacteria through a series of biochemical reactions. It is catalase-positive, which can break down hydrogen peroxide into water and oxygen. It is urease-negative, pyrazinamidase-negative, and nitrate-reducing. Additionally, C. coyleae can ferment glucose and maltose, not sucrose or lactose. These distinct biochemical characteristics help in its identification.
Molecular Methods: Molecular techniques are increasingly important in identifying C. coyleae. 16S rRNA gene sequencing is a reliable method that can confirm its identity and provide insights into its phylogenetic position, differentiating it from closely related species. Other molecular methods, like Polymerase Chain Reaction and MALDI-TOF Mass Spectrometry, can detect and identify C. coyleae in clinical samples, offering a rapid and accurate diagnostic option.
Proper hygiene practices and infection control measures are essential to prevent the transmission of C. coyleae. This bacterium can be transmitted through respiratory droplets, contact with infected materials or lesions, and contaminated personal or household items. To minimize the risk of infection spread, individuals should practice frequent handwashing with water & soap or use alcohol-based hand sanitizers.
Covering the nose & mouth while sneezing or coughing, disposing of used tissues properly, avoiding sharing personal items like towels and razors, and disinfection & diligent cleaning of surfaces and objects can help minimize the risk of transmission.
Additionally, healthcare facilities should implement isolation protocols and protective measures when handling infected patients or specimens.
Corynebacterium coyleae is a bacterial species commonly found as part of the normal microbial flora inhabiting various human body sites, including the skin, urethra, mucous membranes, and genital tract. However, under certain circumstances, particularly in individuals with underlying medical conditions or compromised immune systems, C. coyleae can become pathogenic and lead to infections.
When considering the epidemiological and numerical data related to C. coyleae infections, it’s crucial to note that such cases are relatively rare. Research conducted in Poland over 22 months found that C. coyleae accounted for only 0.32% of cultured urine samples, indicating its infrequent occurrence as a urinary tract pathogen.
Additionally, C. coyleae is not commonly isolated from other clinical samples such as blood cultures, pleural fluid, or soft tissue, although it has been implicated in pancreatic abscesses.Since its initial description in 1997, there have been only a few reported cases of C. coyleae infections in the medical literature. These cases have been associated with various clinical presentations, including fever of unknown origin, sepsis, and post-surgical complications.
Some instances have also been linked to specific conditions such as HIV infection, neonatal bacteremia, burn injuries, and ulcers. Although there have been no reported outbreaks of C. coyleae infection, it’s worth noting that two patients from the same hospital were found to have identical strains of the bacterium isolated from their blood cultures, raising the possibility of nosocomial transmission.
Finally, concerning the clinical outcomes and antibiotic resistance patterns associated with C. coyleae infections, a study reported a mortality rate of 16.7% among patients with C. coyleae bacteremia. Regarding antibiotic susceptibility, C. coyleae exhibited high resistance rates to ciprofloxacin and erythromycin but remained susceptible to vancomycin and linezolid, highlighting the importance of appropriate antibiotic selection in managing infections caused by this bacterium.
Classification and Structure:
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Mycobacteriales
Family: Corynebacteriaceae
Genus:Corynebacterium
Species:Corynebacterium coyleae
Corynebacterium coyleae are slender, straight, or slightly curved rods, typically exhibiting clubbing at one or both sides due to the presence of metachromatic granules, which store phosphate reserves.
Their dimensions typically range from 2 to 6 μm in length & 0.5 μm in diameter. These bacteria are catalase-positive, capable of breaking down hydrogen peroxide into water and oxygen.
Unlike some bacteria, they do not form spores—resistant structures for survival in harsh conditions. Furthermore, Corynebacterium coyleae lack flagella, whip-like appendages used by certain bacteria for movement.
Corynebacterium coyleae shares certain antigens, such as cell wall lipoteichoic acid (LTA) and the iron-regulated surface determinant (ISD) system, with the pathogenic bacterium Corynebacterium diphtheriae, known for causing diphtheria—a potentially fatal respiratory infection. These shared antigens contribute to C. coyleae‘s ability to adhere to host tissues, invade them, and evade host immune responses, shedding light on its pathogenic mechanisms.
Moreover, C. coyleae possesses genes like biofilm-associated protein (bap), promoting biofilm formation, and corynomycolic acid synthase (mas), responsible for synthesizing corynomycolic acids—a component of the bacterial cell envelope that confers resistance to antibiotics and host defenses.
These genetic attributes enhance C. coyleae‘s virulence and resistance capabilities.Numerous strains of C. coyleae, including CCUG 38194, DSM 44184, ATCC 700219, JCM 10381, and CCM 4669, have been documented in scientific literature, underlining this bacterium’s diversity and clinical significance.
Corynebacterium coyleae possesses several distinctive traits contributing to its pathogenic potential and clinical impact. One of its notable abilities is its ability to breach and adhere to human epithelial cells, particularly in the urinary tract. This capability is facilitated by the expression of fimbriae, hair-like appendages crucial in mediating bacterial attachment to host cells. This adherence and invasion can lead to urinary tract infections, causing discomfort and clinical symptoms in affected individuals.
In addition to urinary tract infections, C. coyleae has been associated with the development of necrotizing fasciitis, an exceptionally severe and potentially life-threatening infection characterized by the rapid destruction of soft tissues. This condition can escalate swiftly and necessitates immediate medical intervention to prevent its potentially fatal consequences. Furthermore, C. coyleae infections, particularly in the pancreas, may mimic malignant tumors, necessitating surgical drainage for resolution.
Another notable aspect of C. coyleae‘s pathogenicity is its capacity to form biofilms. Biofilms grow as complex communities of bacterial colonies encased in a protective matrix, which can enhance their persistence and resistance to antibiotics. This protective mechanism can make C. coyleae infections challenging to treat, as they may become more resistant to antimicrobial therapies.
Additionally, C. coyleae may exhibit intrinsic or acquired resistance to various antibiotics, including erythromycin and clindamycin, further complicating treatment strategies. In some cases, C. coyleae‘s ability to evade the effects of antibiotics can lead to persistent or recurrent infections in affected patients,
The human host defense against Corynebacterium coyleae, a prominent member of the skin microbiota, involves a fascinating interplay with the immune system, particularly the activation of γδ T cells and the modulation of immune responses:
Corynebacterium coyleae can induce a significant increase in both the number and activation of a specific subset of γδ T cells within the skin. This activation is characterized by the production of interleukin-17A (IL-17A), a crucial cytokine in immune responses.
Notably, this effect is enduring and occurs independently of other microbial influences, underscoring the unique relationship between C. coyleae and these γδ T cells. The involvement of interleukin-23 (IL-23) in mediating this response further highlights the complexity of the host’s immune defense mechanisms against C. coyleae.
While Corynebacterium coyleae displays the capacity to activate γδ T cells and induce IL-17A production, it’s important to note that the influence of different Corynebacterium species on host immunity may vary.
This species-specific impact adds complexity to the intricate interactions between the host’s immune system and distinct members of the skin microbiota.The immunomodulatory properties of certain Corynebacterium species, exemplified by Corynebacterium parvum, have been explored in experimental vaccine trials.
These studies have demonstrated that specific Corynebacterium species can enhance immune responses, including CD4+ and CD8+ T cell responses, interferon-gamma (IFN-γ) production, and T cell proliferation. The potential adjuvant effects of these bacteria can significantly bolster the host’s immune defenses, as evidenced by prolonged IFN-γ production and T cell proliferation following vaccination.
Corynebacterium coyleae is associated with various clinical manifestations, primarily affecting different body systems. In urinary tract infections (UTIs), C. coyleae commonly afflicts women and men to a lesser extent. UTI symptoms encompass frequent urination, dysuria, a sense of urgency, hematuria (blood in the urine), and lower abdominal discomfort.
Moreover, C. coyleae can advance into the bloodstream, precipitating bacteremia—a grave condition that can potentially lead to sepsis and shock. Manifestations of bacteremia involve fever, chills, hypotension (low blood pressure), tachycardia (rapid heartbeat), and signs of organ dysfunction.
This pathogen is not confined to the urinary tract; it can invade the skin and soft tissues, culminating in inflammation, pain, swelling, erythema (redness), and pus formation. These soft tissue infections can extend into subcutaneous layers, muscles, fascia, or bone.
Additionally, C. coyleae can infect the pancreas, precipitating the formation of abscesses inside the organ. Symptoms indicative of a pancreatic abscess include abdominal pain, nausea, vomiting, unintended weight loss, and fever.
Diagnosing Corynebacterium coyleae infections involves several laboratory techniques and tests to identify and differentiate this bacterium from other species accurately. These diagnostic methods are essential for effective clinical management:
Culture: One of the primary diagnostic methods for C. coyleae is culturing clinical specimens, including blood, urine, pleural fluid, soft tissue, and pancreatic abscess samples. These specimens are typically cultured on specialized media such as chocolate agar & blood agar under aerobic conditions at 35°C for 24 to 48 hours. C. coyleae colonies typically appear small, smooth, and convex and range in color from white to gray. They are nonhemolytic and may exhibit a distinctive brown halo on Tinsdale agar due to hydrogen sulfide production.
Gram Stain: Gram staining is a valuable initial step in identifying C. coyleae. Under the microscope, C. coyleae cells appear Gram-positive and are typically present as thin, straight, or slightly curved rods. They may exhibit clubbing at the ends due to the presence of metachromatic granules, and their arrangement can be irregular, including palisades, V-shapes, or Chinese letter formations.
Biochemical Reactions:C. coyleae can be differentiated from other corynebacteria through a series of biochemical reactions. It is catalase-positive, which can break down hydrogen peroxide into water and oxygen. It is urease-negative, pyrazinamidase-negative, and nitrate-reducing. Additionally, C. coyleae can ferment glucose and maltose, not sucrose or lactose. These distinct biochemical characteristics help in its identification.
Molecular Methods: Molecular techniques are increasingly important in identifying C. coyleae. 16S rRNA gene sequencing is a reliable method that can confirm its identity and provide insights into its phylogenetic position, differentiating it from closely related species. Other molecular methods, like Polymerase Chain Reaction and MALDI-TOF Mass Spectrometry, can detect and identify C. coyleae in clinical samples, offering a rapid and accurate diagnostic option.
Proper hygiene practices and infection control measures are essential to prevent the transmission of C. coyleae. This bacterium can be transmitted through respiratory droplets, contact with infected materials or lesions, and contaminated personal or household items. To minimize the risk of infection spread, individuals should practice frequent handwashing with water & soap or use alcohol-based hand sanitizers.
Covering the nose & mouth while sneezing or coughing, disposing of used tissues properly, avoiding sharing personal items like towels and razors, and disinfection & diligent cleaning of surfaces and objects can help minimize the risk of transmission.
Additionally, healthcare facilities should implement isolation protocols and protective measures when handling infected patients or specimens.
Corynebacterium coyleae is a bacterial species commonly found as part of the normal microbial flora inhabiting various human body sites, including the skin, urethra, mucous membranes, and genital tract. However, under certain circumstances, particularly in individuals with underlying medical conditions or compromised immune systems, C. coyleae can become pathogenic and lead to infections.
When considering the epidemiological and numerical data related to C. coyleae infections, it’s crucial to note that such cases are relatively rare. Research conducted in Poland over 22 months found that C. coyleae accounted for only 0.32% of cultured urine samples, indicating its infrequent occurrence as a urinary tract pathogen.
Additionally, C. coyleae is not commonly isolated from other clinical samples such as blood cultures, pleural fluid, or soft tissue, although it has been implicated in pancreatic abscesses.Since its initial description in 1997, there have been only a few reported cases of C. coyleae infections in the medical literature. These cases have been associated with various clinical presentations, including fever of unknown origin, sepsis, and post-surgical complications.
Some instances have also been linked to specific conditions such as HIV infection, neonatal bacteremia, burn injuries, and ulcers. Although there have been no reported outbreaks of C. coyleae infection, it’s worth noting that two patients from the same hospital were found to have identical strains of the bacterium isolated from their blood cultures, raising the possibility of nosocomial transmission.
Finally, concerning the clinical outcomes and antibiotic resistance patterns associated with C. coyleae infections, a study reported a mortality rate of 16.7% among patients with C. coyleae bacteremia. Regarding antibiotic susceptibility, C. coyleae exhibited high resistance rates to ciprofloxacin and erythromycin but remained susceptible to vancomycin and linezolid, highlighting the importance of appropriate antibiotic selection in managing infections caused by this bacterium.
Classification and Structure:
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Mycobacteriales
Family: Corynebacteriaceae
Genus:Corynebacterium
Species:Corynebacterium coyleae
Corynebacterium coyleae are slender, straight, or slightly curved rods, typically exhibiting clubbing at one or both sides due to the presence of metachromatic granules, which store phosphate reserves.
Their dimensions typically range from 2 to 6 μm in length & 0.5 μm in diameter. These bacteria are catalase-positive, capable of breaking down hydrogen peroxide into water and oxygen.
Unlike some bacteria, they do not form spores—resistant structures for survival in harsh conditions. Furthermore, Corynebacterium coyleae lack flagella, whip-like appendages used by certain bacteria for movement.
Corynebacterium coyleae shares certain antigens, such as cell wall lipoteichoic acid (LTA) and the iron-regulated surface determinant (ISD) system, with the pathogenic bacterium Corynebacterium diphtheriae, known for causing diphtheria—a potentially fatal respiratory infection. These shared antigens contribute to C. coyleae‘s ability to adhere to host tissues, invade them, and evade host immune responses, shedding light on its pathogenic mechanisms.
Moreover, C. coyleae possesses genes like biofilm-associated protein (bap), promoting biofilm formation, and corynomycolic acid synthase (mas), responsible for synthesizing corynomycolic acids—a component of the bacterial cell envelope that confers resistance to antibiotics and host defenses.
These genetic attributes enhance C. coyleae‘s virulence and resistance capabilities.Numerous strains of C. coyleae, including CCUG 38194, DSM 44184, ATCC 700219, JCM 10381, and CCM 4669, have been documented in scientific literature, underlining this bacterium’s diversity and clinical significance.
Corynebacterium coyleae possesses several distinctive traits contributing to its pathogenic potential and clinical impact. One of its notable abilities is its ability to breach and adhere to human epithelial cells, particularly in the urinary tract. This capability is facilitated by the expression of fimbriae, hair-like appendages crucial in mediating bacterial attachment to host cells. This adherence and invasion can lead to urinary tract infections, causing discomfort and clinical symptoms in affected individuals.
In addition to urinary tract infections, C. coyleae has been associated with the development of necrotizing fasciitis, an exceptionally severe and potentially life-threatening infection characterized by the rapid destruction of soft tissues. This condition can escalate swiftly and necessitates immediate medical intervention to prevent its potentially fatal consequences. Furthermore, C. coyleae infections, particularly in the pancreas, may mimic malignant tumors, necessitating surgical drainage for resolution.
Another notable aspect of C. coyleae‘s pathogenicity is its capacity to form biofilms. Biofilms grow as complex communities of bacterial colonies encased in a protective matrix, which can enhance their persistence and resistance to antibiotics. This protective mechanism can make C. coyleae infections challenging to treat, as they may become more resistant to antimicrobial therapies.
Additionally, C. coyleae may exhibit intrinsic or acquired resistance to various antibiotics, including erythromycin and clindamycin, further complicating treatment strategies. In some cases, C. coyleae‘s ability to evade the effects of antibiotics can lead to persistent or recurrent infections in affected patients,
The human host defense against Corynebacterium coyleae, a prominent member of the skin microbiota, involves a fascinating interplay with the immune system, particularly the activation of γδ T cells and the modulation of immune responses:
Corynebacterium coyleae can induce a significant increase in both the number and activation of a specific subset of γδ T cells within the skin. This activation is characterized by the production of interleukin-17A (IL-17A), a crucial cytokine in immune responses.
Notably, this effect is enduring and occurs independently of other microbial influences, underscoring the unique relationship between C. coyleae and these γδ T cells. The involvement of interleukin-23 (IL-23) in mediating this response further highlights the complexity of the host’s immune defense mechanisms against C. coyleae.
While Corynebacterium coyleae displays the capacity to activate γδ T cells and induce IL-17A production, it’s important to note that the influence of different Corynebacterium species on host immunity may vary.
This species-specific impact adds complexity to the intricate interactions between the host’s immune system and distinct members of the skin microbiota.The immunomodulatory properties of certain Corynebacterium species, exemplified by Corynebacterium parvum, have been explored in experimental vaccine trials.
These studies have demonstrated that specific Corynebacterium species can enhance immune responses, including CD4+ and CD8+ T cell responses, interferon-gamma (IFN-γ) production, and T cell proliferation. The potential adjuvant effects of these bacteria can significantly bolster the host’s immune defenses, as evidenced by prolonged IFN-γ production and T cell proliferation following vaccination.
Corynebacterium coyleae is associated with various clinical manifestations, primarily affecting different body systems. In urinary tract infections (UTIs), C. coyleae commonly afflicts women and men to a lesser extent. UTI symptoms encompass frequent urination, dysuria, a sense of urgency, hematuria (blood in the urine), and lower abdominal discomfort.
Moreover, C. coyleae can advance into the bloodstream, precipitating bacteremia—a grave condition that can potentially lead to sepsis and shock. Manifestations of bacteremia involve fever, chills, hypotension (low blood pressure), tachycardia (rapid heartbeat), and signs of organ dysfunction.
This pathogen is not confined to the urinary tract; it can invade the skin and soft tissues, culminating in inflammation, pain, swelling, erythema (redness), and pus formation. These soft tissue infections can extend into subcutaneous layers, muscles, fascia, or bone.
Additionally, C. coyleae can infect the pancreas, precipitating the formation of abscesses inside the organ. Symptoms indicative of a pancreatic abscess include abdominal pain, nausea, vomiting, unintended weight loss, and fever.
Diagnosing Corynebacterium coyleae infections involves several laboratory techniques and tests to identify and differentiate this bacterium from other species accurately. These diagnostic methods are essential for effective clinical management:
Culture: One of the primary diagnostic methods for C. coyleae is culturing clinical specimens, including blood, urine, pleural fluid, soft tissue, and pancreatic abscess samples. These specimens are typically cultured on specialized media such as chocolate agar & blood agar under aerobic conditions at 35°C for 24 to 48 hours. C. coyleae colonies typically appear small, smooth, and convex and range in color from white to gray. They are nonhemolytic and may exhibit a distinctive brown halo on Tinsdale agar due to hydrogen sulfide production.
Gram Stain: Gram staining is a valuable initial step in identifying C. coyleae. Under the microscope, C. coyleae cells appear Gram-positive and are typically present as thin, straight, or slightly curved rods. They may exhibit clubbing at the ends due to the presence of metachromatic granules, and their arrangement can be irregular, including palisades, V-shapes, or Chinese letter formations.
Biochemical Reactions:C. coyleae can be differentiated from other corynebacteria through a series of biochemical reactions. It is catalase-positive, which can break down hydrogen peroxide into water and oxygen. It is urease-negative, pyrazinamidase-negative, and nitrate-reducing. Additionally, C. coyleae can ferment glucose and maltose, not sucrose or lactose. These distinct biochemical characteristics help in its identification.
Molecular Methods: Molecular techniques are increasingly important in identifying C. coyleae. 16S rRNA gene sequencing is a reliable method that can confirm its identity and provide insights into its phylogenetic position, differentiating it from closely related species. Other molecular methods, like Polymerase Chain Reaction and MALDI-TOF Mass Spectrometry, can detect and identify C. coyleae in clinical samples, offering a rapid and accurate diagnostic option.
Proper hygiene practices and infection control measures are essential to prevent the transmission of C. coyleae. This bacterium can be transmitted through respiratory droplets, contact with infected materials or lesions, and contaminated personal or household items. To minimize the risk of infection spread, individuals should practice frequent handwashing with water & soap or use alcohol-based hand sanitizers.
Covering the nose & mouth while sneezing or coughing, disposing of used tissues properly, avoiding sharing personal items like towels and razors, and disinfection & diligent cleaning of surfaces and objects can help minimize the risk of transmission.
Additionally, healthcare facilities should implement isolation protocols and protective measures when handling infected patients or specimens.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
